pur CC cream SPF 40 LIGHT description, usages, side effects, indications, overdosage, supplying and lots more!

pur CC cream SPF 40 LIGHT

PUR MINERALS

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
PUR CC CREAM LIGHT



FULL PRESCRIBING INFORMATION

Active ingredient

Active Ingredient : Titanium Dioxide 10 % , Homosalate 10% , Octinoxate 7.5%

Purpose

Purpose : Sunscreen

Do not use on damaged or broken Skin. Stop use and ask a doctor if rash occurs.

Keep Out of Reach of Children .

Inactive Ingredients : Water,C12-15 Alkyl Benzoate, Cetyl Alcohol,PEG-8,PPG-10 Butanediol, Propanediol , Glyceryl Stearate , PEG-100 Stearate , Triticum Vulgare (Wheat) Germ Extract , Butylene Glycol , Spiraea Ulmaria Extract , Hydrolyzed Ceratonia Siliqua Seed Extract, Xylitylglucoside , Anhydroxylitol , Xylitol , Hydroxyethyl Acrylate/Sodium Acrylodimethyl Taurate Copolymer , Isohexadecane , Polysorbate 60 ,Glycerin , Hydroxypropyl Cyclodextrin , Palmitoyl Tripeptide -38 , Niacinamide , Boron Nitride , Sodium Starch Octenylsuccinate , Lactic Acid , Butyrospermum Parkii (Shea Butter) , Retinol , Ceramide AP , Phenoxyethanol , Caprylyl Glycol , Sorbic Acid , Iron Oxide (CI 77491,CI 77492,CI77499)

For external use only. 

pur CC cream SPF 40 LIGHT

Octinoxate ,Homosalate, Titanium Dioxide CREAM

Product Information

Product Type Cosmetic Item Code (Source) NDC:67345-7050
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 3.3 g
HOMOSALATE Homosalate 4.4 g
titanium dioxide 4.4 g

Inactive Ingredients

Ingredient Name Strength
water
PROPANEDIOL
C12-15 ALKYL BENZOATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:67345-7050-0 44 in 1 TUBE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-07-02


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.